- World Pharma News Home » Financial » Roche posts sustained double-digit sales growth for the first nine months of 2008
(a free service delivered by FeedBurner)
Sales by the Roche Group in the first nine months of 2008 increased by 6% in local currencies (-2% in Swiss francs; 13% in US dollars) to 33.3 billion Swiss francs. Excluding Tamiflu pandemic sales to governments and corporations, sales rose 10% (2% in Swiss francs; 17% in US dollars). The rise in the Swiss franc against most currencies, particularly against the US dollar, resulted in Swiss franc growth being eight percentage points lower than growth in local currencies.
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Comments